Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage
A. M. Amen, C. Fellmann, K. M. Soczek, S. M. Ren, R. J. Lew, G. J. Knott, J. E. Park, A. M. McKinney, A. Mancini, J. A. Doudna, J. F. Costello
This study shows that reducing GABPB1L in TERT-mutant glioblastomas, combined with chemotherapy, reduces tumor growth by impairing DNA damage response.
Proceedings of the National Academy of Sciences · Mar 23, 2021Peer-reviewedCancer Biology